sprite-preloader
Anzeige
Mehr »
Donnerstag, 29.06.2017 Börsentäglich über 12.000 News von 558 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiFormer Ariad employees, spouse face insider trading charges
MiJ&J CEO says real healthcare reform takes time-and cooperation
MiValeant could be hit hardest by FDA generics push: analyst
MiICER to work with VA on its drug price choices and payments
MiShould Merck file anacetrapib with FDA? It's asking experts now
MiBI, Lilly hit the streets to talk up Jardiance's CV benefits
MiHoping to widen Nucala's reach, GSK launches nasal polyps trial
MiMonster headache? It could be a migraine, Promius PSA says
MiMerck targeted in global ransomware attack
DiBavarian Nordic posts positive phase 2 for universal RSV shot
DiSenators call for hearing on Sanofi Zika license
DiFDA rolls out hit list of brands that lack copycat rivals
DiShkreli jury pool shrinks as prospects blast 'pharma bro' for greed
DiStada buyout bombs as shareholder support comes up short
DiCDC committee spurns AstraZeneca's FluMist-again
MoTakeda's Adcetris hits lymphoma trial goal, but not by much
MoTakeda pushes FDA to knock back Velcade copycats
MoPortola navigates bumpy route to Bevyxxa approval
MoAfter a slow 2016, FDA's racking up drug approvals lickety-split
MoAstraZeneca at Cannes: Healthcare's speeding away from pharma marketing
MoPharma pulls back the curtain on marketing at Lions
MoThe big picture: Can pharma creativity compete?
FrHumira facing new threat in EU as Samsung gets nod for biosimilar
FrFDA signs off on Novartis' targeted lung cancer combo
FrRoche's Ocrevus racks up more positive MS data